These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7359665)

  • 21. Comparison of dopamine and norepinephrine in shock.
    Romero CM
    N Engl J Med; 2010 Jun; 362(24):2328; author reply 2330-1. PubMed ID: 20554990
    [No Abstract]   [Full Text] [Related]  

  • 22. Comment on "Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?" by P. Asfar.
    De Keulenaer BL; Stephens DP
    Intensive Care Med; 2003 May; 29(5):854; author reply 855. PubMed ID: 12655391
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effectiveness of various dopamine doses in acute myocardial ischemia complicated by cardiogenic shock (an experimental study)].
    Kipshidze NN; Korotkov AA; Marsagishvili LA; Prigolashvili TSh; Bokhua MR
    Kardiologiia; 1981 Jun; 21(6):80-4. PubMed ID: 7265638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of combined dopamine and nitroprusside therapy in patients with severe pump failure and hypotension complicating acute myocardial infarction.
    Keung EC; Ribner HS; Schwartz W; Sonnenblick EH; LeJemtel TH
    J Cardiovasc Pharmacol; 1980; 2(2):113-9. PubMed ID: 6171679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of intractable septic shock with norepinephrine therapy.
    Meadows D; Edwards JD; Wilkins RG; Nightingale P
    Crit Care Med; 1988 Jul; 16(7):663-6. PubMed ID: 3371042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporizing surgical management improves outcome in patients with Vibrio necrotizing fasciitis complicated with septic shock on admission.
    Hong GL; Dai XQ; Lu CJ; Liu JM; Zhao GJ; Wu B; Li MF; Lu ZQ
    Burns; 2014 May; 40(3):446-54. PubMed ID: 24138809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of dopexamine hydrochloride in patients with septic shock.
    Colardyn FC; Vandenbogaerde JF; Vogelaers DP; Verbeke JH
    Crit Care Med; 1989 Oct; 17(10):999-1003. PubMed ID: 2791586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasopressin in sepsis and septic shock.
    Kampmeier TG; Rehberg S; Westphal M; Lange M
    Minerva Anestesiol; 2010 Oct; 76(10):844-50. PubMed ID: 20935620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of dopamine in patients with cardiogenic shock.
    Holzer J; Karliner JS; O'Rourke RA; Pitt W; Ross J
    Am J Cardiol; 1973 Jul; 32(1):79-84. PubMed ID: 4713114
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and safety of naloxone in septic shock.
    Rock P; Silverman H; Plump D; Kecala Z; Smith P; Michael JR; Summer W
    Crit Care Med; 1985 Jan; 13(1):28-33. PubMed ID: 3965246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Push-Dose Vasopressin for Hypotension in Septic Shock.
    Nowadly CD; Catlin JR; Fontenette RW
    J Emerg Med; 2020 Feb; 58(2):313-316. PubMed ID: 32173168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II receptor type 1 blockade improves hyporesponsiveness to vasopressors in septic shock.
    Fernandes D; Pacheco LK; Sordi R; Scheschowitsch K; Ramos GC; Assreuy J
    Eur J Pharmacol; 2021 Apr; 897():173953. PubMed ID: 33617825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naloxone in shock.
    Lancet; 1980 Dec 20-27; 2(8208-8209):1360. PubMed ID: 6109169
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter: Gangrene aggravation after use of dopamine.
    Julka NK; Nora JR
    JAMA; 1976 Jun; 235(26):2812-3. PubMed ID: 946980
    [No Abstract]   [Full Text] [Related]  

  • 35. Concurrence of symmetrical peripheral gangrene and venous limb gangrene following polytrauma: a case report.
    Tan JH; Mohamad Y; Tan CLH; Kassim M; Warkentin TE
    J Med Case Rep; 2018 May; 12(1):131. PubMed ID: 29776439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of dopamine on cardiogenic and endotoxin experimental shock.
    Marchetti G; Longo T; Merlo L; Noseda V
    Eur Surg Res; 1973; 5(3):175-85. PubMed ID: 4584042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of vasopressor agents in critically ill patients.
    Kellum JA; Pinsky MR
    Curr Opin Crit Care; 2002 Jun; 8(3):236-41. PubMed ID: 12386503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vasospasm following liver rupture, dopamine and hydergine infusion].
    Unseld H
    Anasth Intensivther Notfallmed; 1985 Dec; 20(6):339-41. PubMed ID: 4091240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal gangrene of the extremities.
    Letts M; Blastorah B; al-Azzam S
    J Pediatr Orthop; 1997; 17(3):397-401. PubMed ID: 9150032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of limb loss despite a patent endovascular-treated arterial segment.
    Khan MU; Lall P; Harris LM; Dryjski ML; Dosluoglu HH
    J Vasc Surg; 2009 Jun; 49(6):1440-5; discussion 1445-6. PubMed ID: 19497503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.